Mandate

Vinge advises Stendörren in connection with issuance of green notes and tender offer

September 13, 2024

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of senior unsecured green notes in an amount of SEK 800 million (within a framework of SEK 1200 million) and its parallel tender offer in respect of its previously issued notes due 2025.

An amount corresponding to the net proceeds from the new notes will be used in accordance with Stendörren’s previously established green financing framework and to repurchase parts of Stendörren’s outstanding senior unsecured notes due 2025.

The notes are intended to be listed on the sustainable bond list of Nasdaq Stockholm. The notes have a tenor of 3.25 years and were issued with a coupon of STIBOR 3m + 290 basis points.

Nordea Bank Abp, Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ) acted as joint bookrunners and dealer managers in the transaction.

Vinge’s team consisted of Mikael Ståhl, Lionardo Ojeda, August Ahlin and Rebecka Margolin.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025